An Open Label, Prospective, Multi Center, Clinical study to evaluate efficacy and safety of Arthrohills Capsules in subjects suffering from Osteoarthritis of Knee(s) - NI

Herbal Hills Ltd0 个研究点目标入组 33 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Symptoms of osteoarthritis in one or both knee joints for a minimum of six months and maximum for five years
•2. History of knee pain due to osteoarthritis requiring the use of NSAIDs, Acetaminophen, or another analgesic agent on a regular basis i.e. greater than or equal to three days per week for at least six months before the screening visit
•3. OA confirmed by radiographs and diagnosed according to ACR diagnostic Criteria
•4. Subjects with pain VAS greater than or equal to 40 mm on weight bearing activities

•1. Rheumatoid arthritis, gout, pseudo gout, inflammatory arthritis, Pagets disease of bone, chronic pain syndrome, fibromyalgia, or another major joint disease
•2. History of surgery, including arthroscopy, or major trauma to the study joint in the previous six months before the screening visit
•3. Subjects requiring knee arthroplasty within 6 months of screening or anticipating any need for a surgical procedure on the index joint during the study
•4. Use of systemic corticosteroids within 2 months of screening, or intra-articular visco supplementation within the past 3 months
•5. Subjects having diabetes mellitus, tuberculosis, HIV, Ischemic Heart Disease
•6. Known other major medical or surgical disease
•7. Pregnancy and Lactation.

发起方

Herbal Hills Ltd